Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
87.8M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
11.6M
-
Shares change
-
+541K
-
Total reported value, excl. options
-
$4.89M
-
Value change
-
+$37.4K
-
Number of buys
-
20
-
Number of sells
-
-16
-
Price
-
$0.42
Significant Holders of COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) as of Q1 2025
53 filings reported holding CGTX - COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share as of Q1 2025.
COGNITION THERAPEUTICS INC - Common Stock, par value $0.001 per share (CGTX) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.6M shares
of 87.8M outstanding shares and own 13.24% of the company stock.
Largest 10 shareholders include BIOS Capital Management, LP (6M shares), VANGUARD GROUP INC (1.24M shares), ACADIAN ASSET MANAGEMENT LLC (1.01M shares), Sigma Planning Corp (608K shares), Voss Capital, LP (450K shares), CM Management, LLC (400K shares), GEODE CAPITAL MANAGEMENT, LLC (369K shares), AMERICAN FINANCIAL GROUP INC (205K shares), Kestra Advisory Services, LLC (177K shares), and BlackRock, Inc. (155K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.